NCT00478764

Brief Summary

The use of one dose of an antibiotic and steroid injected into the eye at the end of cataract surgery is as safe and effective as the post operative use of eyedrops after cataract surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2006

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2007

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 24, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 25, 2007

Completed
Last Updated

May 25, 2007

Status Verified

May 1, 2007

First QC Date

May 24, 2007

Last Update Submit

May 24, 2007

Conditions

Cataract

Keywords

intraoculartriamcinolonegatifloxicininflammationvisual acuity

Outcome Measures

Primary Outcomes (1)

  • visual acuity

    90 days

Secondary Outcomes (1)

  • intraocular inflammation

    90 days

Interventions

intraocular triamcinolone and gatifloxicinDRUG

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Davis Duehr Dean Baraboo

Baraboo, Wisconsin, 53913, United States

Location

Related Publications (1)

  • Gills JP, Gills P. Effect of intracameral triamcinolone to control inflammation following cataract surgery. J Cataract Refract Surg. 2005 Aug;31(8):1670-1. doi: 10.1016/j.jcrs.2005.07.023. No abstract available.

    PMID: 16129313BACKGROUND

MeSH Terms

Conditions

CataractInflammation

Condition Hierarchy (Ancestors)

Lens DiseasesEye DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jonathan G Stock, MD

    Dean Health Systems

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 24, 2007

First Posted

May 25, 2007

Study Start

March 1, 2006

Study Completion

April 1, 2007

Last Updated

May 25, 2007

Record last verified: 2007-05

Locations

US(1)